{"id":240,"date":"2020-04-06T01:47:25","date_gmt":"2020-04-06T01:47:25","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=240"},"modified":"2023-08-29T17:44:46","modified_gmt":"2023-08-29T17:44:46","slug":"mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=240","title":{"rendered":"Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005"},"content":{"rendered":"<p>\u518d\u751f\u533b\u5b66\u516c\u53f8Mesoblast (ASX: MSB)\u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(fda)\u7684\u7814\u7a76\u65b0\u836f(IND)\u8bb8\u53ef\uff0c\u5141\u8bb8\u5176\u5bf9COVID19\u60a3\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u8fdb\u884c\u5fc5\u8981\u7684\u6cbb\u7597\u3002<\/p>\n<p>\u636eMesoblast\u9996\u5e2d\u533b\u7597\u5b98Fred Grossman\u535a\u58eb\u8bf4\uff0cFDA IND\u6279\u51c6\u73b0\u5728\u5141\u8bb8\u7f8e\u56fdCOVID19\u9884\u540e\u4e0d\u826f\u7684\u60a3\u8005\u5728\u57fa\u4e8e\u540c\u60c5\u7684\u4f7f\u7528\u7406\u7531\u548c\u8ba1\u5212\u7684\u968f\u673a\u5bf9\u7167\u8bd5\u9a8c\u4e2d\u4f7f\u7528\u7ef4\u751f\u7d20l\u8fdb\u884c\u6cbb\u7597\u3002<\/p>\n<p>Remestemcel-L\u662f\u4e00\u79cd\u6297\u708e\u6cbb\u7597\u836f\u7269\uff0c\u5df2\u88ab\u5f00\u53d1\u7528\u4e8e\u5404\u79cd\u708e\u75c7\u60c5\u51b5\uff0c\u5305\u62ec\u7c7b\u56fa\u9187\u96be\u6cbb\u6027\u6025\u6027\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\u3002<\/p>\n<p>Mesoblast\u58f0\u79f0\uff0c\u8fd9\u79cd\u836f\u7269\u7684\u4f5c\u7528\u662f\u901a\u8fc7\u4e0b\u8c03\u4fc3\u708e\u7ec6\u80de\u56e0\u5b50\u7684\u4ea7\u751f\u6765\u62b5\u6d88\u8fd9\u4e9b\u75be\u75c5\u4e2d\u7684\u708e\u75c7\u8fc7\u7a0b\uff0c\u540c\u65f6\u589e\u52a0\u6297\u708e\u7ec6\u80de\u56e0\u5b50\u7684\u4ea7\u751f\uff0c\u4f7f\u6297\u708e\u7ec6\u80de\u80fd\u591f\u52df\u96c6\u5230\u76f8\u5173\u7ec4\u7ec7\u3002<\/p>\n<p>\u8fc4\u4eca\u4e3a\u6b62\uff0c\u5bf91100\u591a\u540d\u60a3\u8005\u8fdb\u884c\u4e86\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e86\u9759\u8109\u8f93\u6db2\u7684\u5b89\u5168\u6027\u548c\u6cbb\u7597\u6548\u679c\u3002<\/p>\n<p>\u5728\u4e00\u98793\u671f\u8bd5\u9a8c\u4e2d\uff0c\u7814\u7a76\u4eba\u5458\u53d1\u73b0\uff0cremestemcel-L\u5728\u6cbb\u7597\u6025\u6027\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\u4e2d\u5f88\u6709\u7528\uff0cMesoblast\u58f0\u79f0\uff0c\u8fd9\u79cd\u75c5\u4f1a\u4ea7\u751f\u7c7b\u4f3c\u4e8e\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81COVID-19\u60a3\u8005\u7684\u7ec6\u80de\u56e0\u5b50\u98ce\u66b4\u8fc7\u7a0b\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u4e00\u9879\u6d89\u53ca60\u4f8b\u6162\u6027\u963b\u585e\u6027\u80ba\u75be\u75c5\u60a3\u8005\u7684\u7814\u7a76\u663e\u793a\uff0c\u4e0eCOVID-19\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u60a3\u8005\u76f8\u540c\u7684\u708e\u75c7\u751f\u7269\u6807\u5fd7\u7269\u5347\u9ad8\u7684\u60a3\u8005\uff0c\u5176\u547c\u5438\u9053\u529f\u80fd\u663e\u8457\u6539\u5584\u3002<\/p>\n<h2>\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81<\/h2>\n<p>\u7f79\u60a3\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u98ce\u9669\u6700\u9ad8\u7684COVID-19\u60a3\u8005\u5305\u62ec\u8001\u5e74\u4eba\u548c\u540c\u65f6\u60a3\u6709\u7cd6\u5c3f\u75c5\u7b49\u75be\u75c5\u7684\u60a3\u8005\u3002<\/p>\n<p>\u6839\u636eMesoblast\uff0cCOVID-19\u5df2\u53d1\u5c55\u4e3a\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u6709\u8fd150%\u7684\u81f4\u6b7b\u7387\u3002<\/p>\n<p>Remestemcel-L\u662f\u4e00\u79cd\u5f02\u4f53\u95f4\u5145\u8d28\u5e72\u7ec6\u80de\u4ea7\u54c1\uff0c\u6765\u81ea\u4e2d\u56fd\u7684\u521d\u6b65\u6570\u636e\u8868\u660e\uff0c\u5728\u5c0f\u8bd5\u9a8c\u4e2d\uff0c\u5f02\u4f53\u95f4\u5145\u8d28\u5e72\u7ec6\u80de\u5df2\u6cbb\u6108\u6216\u201c\u663e\u8457\u6539\u5584\u201d7\u4f8bCOVID-19\u60a3\u8005\u7684\u529f\u80fd\u7ed3\u679c\u3002<\/p>\n<p>\u622a\u81f3\u4e0a\u534810\u70b9\u5de6\u53f3\uff0cMesoblast\u80a1\u4ef7\u4e0a\u6da8\u8fd130%\uff0c\u81f31.74\u7f8e\u5143\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u518d\u751f\u533b\u5b66\u516c\u53f8Mesoblast (ASX: MSB)\u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(fda)\u7684\u7814\u7a76\u65b0\u836f(IND)\u8bb8\u53ef\uff0c\u5141\u8bb8\u5176\u5bf9COVID19\u60a3\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u8fdb\u884c\u5fc5\u8981\u7684\u6cbb\u7597\u3002 \u636eMesoblast\u9996\u5e2d\u533b\u7597\u5b98Fred Grossman\u535a\u58eb\u8bf4\uff0cFDA IND\u6279\u51c6\u73b0\u5728\u5141\u8bb8\u7f8e\u56fdCOVID19\u9884\u540e\u4e0d\u826f\u7684\u60a3\u8005\u5728\u57fa\u4e8e\u540c\u60c5\u7684\u4f7f\u7528\u7406\u7531\u548c\u8ba1\u5212\u7684\u968f\u673a\u5bf9\u7167\u8bd5\u9a8c\u4e2d\u4f7f\u7528\u7ef4\u751f\u7d20l\u8fdb\u884c\u6cbb\u7597\u3002 Remestemcel-L\u662f\u4e00\u79cd\u6297\u708e\u6cbb\u7597\u836f\u7269\uff0c\u5df2\u88ab\u5f00\u53d1\u7528\u4e8e\u5404\u79cd\u708e\u75c7\u60c5\u51b5\uff0c\u5305\u62ec\u7c7b\u56fa\u9187\u96be\u6cbb\u6027\u6025\u6027\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\u3002 Mesoblast\u58f0\u79f0\uff0c\u8fd9\u79cd\u836f\u7269\u7684\u4f5c\u7528\u662f\u901a\u8fc7\u4e0b\u8c03\u4fc3\u708e\u7ec6\u80de\u56e0\u5b50\u7684\u4ea7\u751f\u6765\u62b5\u6d88\u8fd9\u4e9b\u75be\u75c5\u4e2d\u7684\u708e\u75c7\u8fc7\u7a0b\uff0c\u540c\u65f6\u589e\u52a0\u6297\u708e\u7ec6\u80de\u56e0\u5b50\u7684\u4ea7\u751f\uff0c\u4f7f\u6297\u708e\u7ec6\u80de\u80fd\u591f\u52df\u96c6\u5230\u76f8\u5173\u7ec4\u7ec7\u3002 \u8fc4\u4eca\u4e3a\u6b62\uff0c\u5bf91100\u591a\u540d\u60a3\u8005\u8fdb\u884c\u4e86\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u4e86\u9759\u8109\u8f93\u6db2\u7684\u5b89\u5168\u6027\u548c\u6cbb\u7597\u6548\u679c\u3002 \u5728\u4e00\u98793\u671f\u8bd5\u9a8c\u4e2d\uff0c\u7814\u7a76\u4eba\u5458\u53d1\u73b0\uff0cremestemcel-L\u5728\u6cbb\u7597\u6025\u6027\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\u4e2d\u5f88\u6709\u7528\uff0cMesoblast\u58f0\u79f0\uff0c\u8fd9\u79cd\u75c5\u4f1a\u4ea7\u751f\u7c7b\u4f3c\u4e8e\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81COVID-19\u60a3\u8005\u7684\u7ec6\u80de\u56e0\u5b50\u98ce\u66b4\u8fc7\u7a0b\u3002 \u6b64\u5916\uff0c\u4e00\u9879\u6d89\u53ca60\u4f8b\u6162\u6027\u963b\u585e\u6027\u80ba\u75be\u75c5\u60a3\u8005\u7684\u7814\u7a76\u663e\u793a\uff0c\u4e0eCOVID-19\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u60a3\u8005\u76f8\u540c\u7684\u708e\u75c7\u751f\u7269\u6807\u5fd7\u7269\u5347\u9ad8\u7684\u60a3\u8005\uff0c\u5176\u547c\u5438\u9053\u529f\u80fd\u663e\u8457\u6539\u5584\u3002 \u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81 \u7f79\u60a3\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u98ce\u9669\u6700\u9ad8\u7684COVID-19\u60a3\u8005\u5305\u62ec\u8001\u5e74\u4eba\u548c\u540c\u65f6\u60a3\u6709\u7cd6\u5c3f\u75c5\u7b49\u75be\u75c5\u7684\u60a3\u8005\u3002 \u6839\u636eMesoblast\uff0cCOVID-19\u5df2\u53d1\u5c55\u4e3a\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u6709\u8fd150%\u7684\u81f4\u6b7b\u7387\u3002 Remestemcel-L\u662f\u4e00\u79cd\u5f02\u4f53\u95f4\u5145\u8d28\u5e72\u7ec6\u80de\u4ea7\u54c1\uff0c\u6765\u81ea\u4e2d\u56fd\u7684\u521d\u6b65\u6570\u636e\u8868\u660e\uff0c\u5728\u5c0f\u8bd5\u9a8c\u4e2d\uff0c\u5f02\u4f53\u95f4\u5145\u8d28\u5e72\u7ec6\u80de\u5df2\u6cbb\u6108\u6216\u201c\u663e\u8457\u6539\u5584\u201d7\u4f8bCOVID-19\u60a3\u8005\u7684\u529f\u80fd\u7ed3\u679c\u3002 \u622a\u81f3\u4e0a\u534810\u70b9\u5de6\u53f3\uff0cMesoblast\u80a1\u4ef7\u4e0a\u6da8\u8fd130%\uff0c\u81f31.74\u7f8e\u5143\u3002<\/p>\n","protected":false},"author":3,"featured_media":241,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[95],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005<\/title>\n<meta name=\"description\" content=\"\u518d\u751f\u533b\u5b66\u516c\u53f8Mesoblast (ASX: MSB)\u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(fda)\u7684\u7814\u7a76\u65b0\u836f(IND)\u8bb8\u53ef\uff0c\u5141\u8bb8\u5176\u5bf9COVID19\u60a3\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u8fdb\u884c\u5fc5\u8981\u7684\u6cbb\u7597\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005\" \/>\n<meta property=\"og:description\" content=\"\u518d\u751f\u533b\u5b66\u516c\u53f8Mesoblast (ASX: MSB)\u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(fda)\u7684\u7814\u7a76\u65b0\u836f(IND)\u8bb8\u53ef\uff0c\u5141\u8bb8\u5176\u5bf9COVID19\u60a3\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u8fdb\u884c\u5fc5\u8981\u7684\u6cbb\u7597\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-06T01:47:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:44:46+00:00\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005\" \/>\n<meta name=\"twitter:description\" content=\"\u518d\u751f\u533b\u5b66\u516c\u53f8Mesoblast (ASX: MSB)\u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(fda)\u7684\u7814\u7a76\u65b0\u836f(IND)\u8bb8\u53ef\uff0c\u5141\u8bb8\u5176\u5bf9COVID19\u60a3\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u8fdb\u884c\u5fc5\u8981\u7684\u6cbb\u7597\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/04\/Mesoblast-acute-respiratory-distress-syndrome-ARDS-COVID-19-ASX-MSB-FDA.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/\",\"name\":\"Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-04-06T01:47:25+00:00\",\"dateModified\":\"2023-08-29T17:44:46+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"\u518d\u751f\u533b\u5b66\u516c\u53f8Mesoblast (ASX: MSB)\u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(fda)\u7684\u7814\u7a76\u65b0\u836f(IND)\u8bb8\u53ef\uff0c\u5141\u8bb8\u5176\u5bf9COVID19\u60a3\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u8fdb\u884c\u5fc5\u8981\u7684\u6cbb\u7597\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005","description":"\u518d\u751f\u533b\u5b66\u516c\u53f8Mesoblast (ASX: MSB)\u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(fda)\u7684\u7814\u7a76\u65b0\u836f(IND)\u8bb8\u53ef\uff0c\u5141\u8bb8\u5176\u5bf9COVID19\u60a3\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u8fdb\u884c\u5fc5\u8981\u7684\u6cbb\u7597\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005","og_description":"\u518d\u751f\u533b\u5b66\u516c\u53f8Mesoblast (ASX: MSB)\u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(fda)\u7684\u7814\u7a76\u65b0\u836f(IND)\u8bb8\u53ef\uff0c\u5141\u8bb8\u5176\u5bf9COVID19\u60a3\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u8fdb\u884c\u5fc5\u8981\u7684\u6cbb\u7597\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/","og_site_name":"smallcapsCN","article_published_time":"2020-04-06T01:47:25+00:00","article_modified_time":"2023-08-29T17:44:46+00:00","author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_title":"Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005","twitter_description":"\u518d\u751f\u533b\u5b66\u516c\u53f8Mesoblast (ASX: MSB)\u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(fda)\u7684\u7814\u7a76\u65b0\u836f(IND)\u8bb8\u53ef\uff0c\u5141\u8bb8\u5176\u5bf9COVID19\u60a3\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u8fdb\u884c\u5fc5\u8981\u7684\u6cbb\u7597\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/04\/Mesoblast-acute-respiratory-distress-syndrome-ARDS-COVID-19-ASX-MSB-FDA.jpg","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/","url":"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/","name":"Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-04-06T01:47:25+00:00","dateModified":"2023-08-29T17:44:46+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"\u518d\u751f\u533b\u5b66\u516c\u53f8Mesoblast (ASX: MSB)\u83b7\u5f97\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(fda)\u7684\u7814\u7a76\u65b0\u836f(IND)\u8bb8\u53ef\uff0c\u5141\u8bb8\u5176\u5bf9COVID19\u60a3\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u60a3\u8005\u8fdb\u884c\u5fc5\u8981\u7684\u6cbb\u7597\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/mesoblast-remestemcel-l-fda-ind-clearance-treating-covid-19-patients-acute-respiratory-distress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Mesoblast\u7684remestemcel-L\u83b7\u5f97FDA\u6279\u51c6\u7528\u4e8e\u6cbb\u7597COVID-19\u4f8b\u6025\u6027\u547c\u5438\u7a98\u8feb\u60a3\u8005"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/240"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=240"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/240\/revisions"}],"predecessor-version":[{"id":7396,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/240\/revisions\/7396"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/241"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}